About Index Trending news
Analyze
Pricing
ImStar Therapeutics

ImStar Therapeutics

ImStar Therapeutics

Developing promising new treatments for Amyotrophic Lateral Sclerosis (ALS) and neurodegenerative diseases

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Employees

Unknown size

Locations
HQ
Headquarters
$1,800,000 Seed fund
PE Hub , BetaKit

Accel-Rx, BDC Capital lead $1.8 mln funding of ImStar Therapeutics